Zhejiang Huahai Pharmaceutical is recalling the valsartan drug sold in the United States after the European Medicines Agency found that it was tainted with an impurity linked to cancer. Photo: Weibo
Beijing orders made-in-China valsartan heart drug pulled from hospitals over cancer risks
Zhejiang Huahai Pharmaceutical version should not be used for treatment or diagnosis, health regulator says
Topic |
Health in China
Zhejiang Huahai Pharmaceutical is recalling the valsartan drug sold in the United States after the European Medicines Agency found that it was tainted with an impurity linked to cancer. Photo: Weibo